Can CRISPR Make CAR T Safer and More Scalable?

Published Date: 10 Jul 2026

Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mental health risk persists years after cancer diagnosis

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Cancer mortality continuing to decline, says report

5.

Doctors say lung cancer is still the deadliest cancer, but hope is growing


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot